• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种遗传性肥胖模型(普拉德-威利综合征和唐氏综合征)中的血清游离瘦素及总瘦素水平和可溶性瘦素受体水平。

Free and total leptin serum levels and soluble leptin receptors levels in two models of genetic obesity: the Prader-Willi and the Down syndromes.

作者信息

Proto Caterina, Romualdi Daniela, Cento Rosa Maria, Romano Corrado, Campagna Giuseppe, Lanzone Antonio

机构信息

Laboratories Department, Oasi Institute for Research Maria SS, 94018 Troina (EN), Italy.

出版信息

Metabolism. 2007 Aug;56(8):1076-80. doi: 10.1016/j.metabol.2007.03.016.

DOI:10.1016/j.metabol.2007.03.016
PMID:17618952
Abstract

Alterations in energy balance and feeding behavior and the subsequent high frequency of obesity are hallmarks of 2 chromosomal diseases: the Prader-Willi syndrome (PWS) and the Down syndrome (DS). Leptin, an important regulator of food intake and energy homeostasis, circulates in 2 forms: a free, therefore active, fraction and a fraction bound to the soluble leptin receptor, whose bioavailability consequently participates in the regulation of leptin action. To investigate the possible role of the free-bound leptin balance in the pathogenesis of obesity in PWS and DS, we enrolled 7 obese women with DS, 5 obese women with PWS, 7 obese women, and 7 normal-weight healthy control women. Basal hormonal concentrations, total and free leptin levels, and leptin receptors levels were measured in plasma samples obtained from the 4 groups. No significant differences were observed in the hormonal milieu. Women with DS exhibited lower total leptin concentrations (P<.01), comparable leptin receptor level and, therefore, lower free leptin values (P<.01) when compared with obese controls, then resembling the profile peculiar to normal-weight control women. At variance, subjects with PWS did not differ from obese controls regarding both leptin and leptin receptor levels. Our data suggest that, whereas subjects with PWS have a leptin assessment corresponding to their degree of obesity, subjects with DS may have a defect in the secretion of leptin that could at least partially account for this form of syndromal obesity.

摘要

能量平衡和进食行为的改变以及随之而来的高肥胖发生率是两种染色体疾病的特征

普拉德-威利综合征(PWS)和唐氏综合征(DS)。瘦素是食物摄入和能量稳态的重要调节因子,以两种形式循环:一种是游离的、因此具有活性的部分,另一种是与可溶性瘦素受体结合的部分,其生物利用度因此参与瘦素作用的调节。为了研究游离-结合瘦素平衡在PWS和DS肥胖发病机制中的可能作用,我们招募了7名肥胖的DS女性、5名肥胖的PWS女性、7名肥胖女性和7名体重正常的健康对照女性。在从这4组中获得的血浆样本中测量基础激素浓度、总瘦素和游离瘦素水平以及瘦素受体水平。在激素环境中未观察到显著差异。与肥胖对照组相比,DS女性的总瘦素浓度较低(P<0.01),瘦素受体水平相当,因此游离瘦素值较低(P<0.01),这与体重正常的对照女性特有的特征相似。与此不同的是,PWS患者在瘦素和瘦素受体水平方面与肥胖对照组没有差异。我们的数据表明,虽然PWS患者的瘦素评估与其肥胖程度相对应,但DS患者可能存在瘦素分泌缺陷,这至少可以部分解释这种综合征性肥胖。

相似文献

1
Free and total leptin serum levels and soluble leptin receptors levels in two models of genetic obesity: the Prader-Willi and the Down syndromes.两种遗传性肥胖模型(普拉德-威利综合征和唐氏综合征)中的血清游离瘦素及总瘦素水平和可溶性瘦素受体水平。
Metabolism. 2007 Aug;56(8):1076-80. doi: 10.1016/j.metabol.2007.03.016.
2
Serum leptin concentrations in obese women with Down syndrome and Prader-Willi syndrome.患有唐氏综合征和普拉德-威利综合征的肥胖女性的血清瘦素浓度。
Gynecol Endocrinol. 1999 Feb;13(1):36-41. doi: 10.1080/09513599909167529.
3
Resting metabolic rate, plasma leptin concentrations, leptin receptor expression, and adipose tissue measured by whole-body magnetic resonance imaging in women with Prader-Willi syndrome.普拉德-威利综合征女性的静息代谢率、血浆瘦素浓度、瘦素受体表达以及通过全身磁共振成像测量的脂肪组织。
Am J Clin Nutr. 2002 Mar;75(3):468-75. doi: 10.1093/ajcn/75.3.468.
4
Comparison of leptin protein levels in Prader-Willi syndrome and control individuals.普拉德-威利综合征与对照个体中瘦素蛋白水平的比较。
Am J Med Genet. 1998 Jan 6;75(1):7-12.
5
Serum leptin concentrations in children with Prader-Willi syndrome and non-syndromal obesity.普拉德-威利综合征患儿与非综合征性肥胖患儿的血清瘦素浓度
J Pediatr Endocrinol Metab. 2000 Apr;13(4):425-30. doi: 10.1515/JPEM.2000.13.4.425.
6
Insulin resistance and obesity-related factors in Prader-Willi syndrome: comparison with obese subjects.普拉德-威利综合征中的胰岛素抵抗及肥胖相关因素:与肥胖受试者的比较
Clin Genet. 2005 Mar;67(3):230-9. doi: 10.1111/j.1399-0004.2004.00392.x.
7
Circulating adiponectin levels, body composition and obesity-related variables in Prader-Willi syndrome: comparison with obese subjects.普拉德-威利综合征患者的循环脂联素水平、身体成分及肥胖相关变量:与肥胖受试者的比较
Int J Obes (Lond). 2006 Feb;30(2):382-7. doi: 10.1038/sj.ijo.0803115.
8
Circulating Levels of Nesfatin-1 and Spexin in Children with Prader-Willi Syndrome during Growth Hormone Treatment and Dietary Intervention.生长激素治疗和饮食干预对 Prader-Willi 综合征患儿循环 nesfatin-1 和 spexin 水平的影响。
Nutrients. 2023 Mar 1;15(5):1240. doi: 10.3390/nu15051240.
9
Leptin concentrations in Prader-Willi syndrome before and after growth hormone replacement.普拉德-威利综合征患者生长激素替代治疗前后的瘦素浓度
Clin Endocrinol (Oxf). 2000 Jan;52(1):101-5. doi: 10.1046/j.1365-2265.2000.00868.x.
10
Ghrelin concentrations in Prader-Willi syndrome (PWS) infants and children: changes during development.普拉德-威利综合征(PWS)婴幼儿的胃饥饿素浓度:发育过程中的变化
Clin Endocrinol (Oxf). 2008 Dec;69(6):911-20. doi: 10.1111/j.1365-2265.2008.03385.x. Epub 2008 Aug 15.

引用本文的文献

1
Updates on Obesity in Prader-Willi Syndrome: From Genetics to Management.普拉德-威利综合征肥胖问题的最新进展:从遗传学到管理
Ewha Med J. 2023 Dec;46(Suppl 1):e33. doi: 10.12771/emj.2023.e33. Epub 2023 Dec 31.
2
Appetite- and weight-inducing and -inhibiting neuroendocrine factors in Prader-Willi syndrome, Bardet-Biedl syndrome and craniopharyngioma versus anorexia nervosa.普拉德-威利综合征、巴德-比德尔综合征和颅咽管瘤与神经性厌食症中影响食欲和体重的神经内分泌诱导及抑制因子
Endocr Connect. 2021 May 19;10(5):R175-R188. doi: 10.1530/EC-21-0111.
3
Metabolic Diseases and Down Syndrome: How Are They Linked Together?
代谢疾病与唐氏综合征:它们是如何联系在一起的?
Biomedicines. 2021 Feb 22;9(2):221. doi: 10.3390/biomedicines9020221.
4
Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions.唐氏综合征是一种代谢性疾病:胰岛素信号改变介导外周和大脑功能障碍。
Front Neurosci. 2020 Jul 8;14:670. doi: 10.3389/fnins.2020.00670. eCollection 2020.
5
Obesity management in Prader-Willi syndrome: current perspectives.普拉德-威利综合征的肥胖管理:当前观点
Diabetes Metab Syndr Obes. 2018 Oct 4;11:579-593. doi: 10.2147/DMSO.S141352. eCollection 2018.
6
C-Reactive Protein (CRP) and Leptin Receptor in Obesity: Binding of Monomeric CRP to Leptin Receptor.C-反应蛋白(CRP)和肥胖症中的瘦素受体:单体 CRP 与瘦素受体的结合。
Front Immunol. 2018 May 29;9:1167. doi: 10.3389/fimmu.2018.01167. eCollection 2018.
7
Body composition, adipokines, bone mineral density and bone remodeling markers in relation to IGF-1 levels in adults with Prader-Willi syndrome.普拉德-威利综合征成人患者的身体成分、脂肪因子、骨矿物质密度和骨重塑标志物与胰岛素样生长因子-1水平的关系
Int J Pediatr Endocrinol. 2018;2018:1. doi: 10.1186/s13633-018-0055-4. Epub 2018 Jan 16.
8
Brain structural alterations in obese children with and without Prader-Willi Syndrome.患有和未患有普拉德-威利综合征的肥胖儿童的脑结构改变
Hum Brain Mapp. 2017 Aug;38(8):4228-4238. doi: 10.1002/hbm.23660. Epub 2017 May 23.
9
Lack of Postprandial Peak in Brain-Derived Neurotrophic Factor in Adults with Prader-Willi Syndrome.普拉德-威利综合征成人患者脑源性神经营养因子餐后峰值缺失
PLoS One. 2016 Sep 29;11(9):e0163468. doi: 10.1371/journal.pone.0163468. eCollection 2016.
10
Health promotion and disease prevention strategies in older adults with intellectual and developmental disabilities.老年智力和发育障碍者的健康促进和疾病预防策略。
Front Public Health. 2014 Apr 14;2:31. doi: 10.3389/fpubh.2014.00031. eCollection 2014.